Zhen Wang, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma (NCT04565327) | Zhen Wang, MD | 2020-08-14 |
| Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors (NCT04258462) | Zhen Wang, MD | 2019-01-15 |
Track Zhen Wang, MD automatically
Every clearance here is in the API, with alerts when new ones post.